These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 38731891)

  • 1. Insights into Inhalation Drug Disposition: The Roles of Pulmonary Drug-Metabolizing Enzymes and Transporters.
    Dong L; Zhuang X
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals.
    Nahar K; Gupta N; Gauvin R; Absar S; Patel B; Gupta V; Khademhosseini A; Ahsan F
    Eur J Pharm Sci; 2013 Aug; 49(5):805-18. PubMed ID: 23797056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay of Drug-Metabolizing Enzymes and Transporters in Drug Absorption and Disposition.
    Shi S; Li Y
    Curr Drug Metab; 2014; 15(10):915-41. PubMed ID: 25828591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Progress Toward a Better Understanding of Drug Disposition Within the Lungs: Summary Proceedings of the First Workshop on Drug Transporters in the Lungs.
    Ehrhardt C; Bäckman P; Couet W; Edwards C; Forbes B; Fridén M; Gumbleton M; Hosoya KI; Kato Y; Nakanishi T; Takano M; Terasaki T; Yumoto R
    J Pharm Sci; 2017 Sep; 106(9):2234-2244. PubMed ID: 28416418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression analysis of membrane transporters and drug-metabolizing enzymes in the lung of healthy and COPD subjects.
    Berg T; Hegelund Myrbäck T; Olsson M; Seidegård J; Werkström V; Zhou XH; Grunewald J; Gustavsson L; Nord M
    Pharmacol Res Perspect; 2014 Aug; 2(4):e00054. PubMed ID: 25505599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Affecting Drug Exposure after Inhalation.
    Nováková A; Šíma M; Slanař O
    Prague Med Rep; 2022; 123(3):129-139. PubMed ID: 36107443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Application of Physiologically Based Pharmacokinetic Modeling to Predict the Role of Drug Transporters: Scientific and Regulatory Perspectives.
    Pan Y; Hsu V; Grimstein M; Zhang L; Arya V; Sinha V; Grillo JA; Zhao P
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S122-31. PubMed ID: 27385170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and Regulation of Drug Transporters and Metabolizing Enzymes in the Human Gastrointestinal Tract.
    Drozdzik M; Oswald S
    Curr Med Chem; 2016; 23(39):4468-4489. PubMed ID: 27781942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery.
    Sakagami M
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1030-60. PubMed ID: 17010473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of models for the evaluation of pulmonary drug disposition.
    Liu X; Jin L; Upham JW; Roberts MS
    Expert Opin Drug Metab Toxicol; 2013 Apr; 9(4):487-505. PubMed ID: 23294005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs.
    Urquhart BL; Tirona RG; Kim RB
    J Clin Pharmacol; 2007 May; 47(5):566-78. PubMed ID: 17442683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: Evidences in inflammatory diseases and age-related disorders.
    Wu KC; Lin CJ
    J Food Drug Anal; 2019 Jan; 27(1):48-59. PubMed ID: 30648594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species.
    van Groen BD; Nicolaï J; Kuik AC; Van Cruchten S; van Peer E; Smits A; Schmidt S; de Wildt SN; Allegaert K; De Schaepdrijver L; Annaert P; Badée J
    Pharmacol Rev; 2021 Apr; 73(2):597-678. PubMed ID: 33608409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-metabolizing Enzymes and Efflux Transporters in Nasal Epithelium: Influence on the Bioavailability of Intranasally Administered Drugs.
    Oliveira P; Fortuna A; Alves G; Falcao A
    Curr Drug Metab; 2016; 17(7):628-47. PubMed ID: 27048181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Systems Biology of Drug Metabolizing Enzymes and Transporters: Relevance to Quantitative Systems Pharmacology.
    Nigam SK; Bush KT; Bhatnagar V; Poloyac SM; Momper JD
    Clin Pharmacol Ther; 2020 Jul; 108(1):40-53. PubMed ID: 32119114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport mechanisms at the pulmonary mucosa: implications for drug delivery.
    Nickel S; Clerkin CG; Selo MA; Ehrhardt C
    Expert Opin Drug Deliv; 2016; 13(5):667-90. PubMed ID: 26909544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and ex vivo models in inhalation biopharmaceutical research - advances, challenges and future perspectives.
    Selo MA; Sake JA; Kim KJ; Ehrhardt C
    Adv Drug Deliv Rev; 2021 Oct; 177():113862. PubMed ID: 34256080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scientific and regulatory perspectives on metabolizing enzyme-transporter interplay and its role in drug interactions: challenges in predicting drug interactions.
    Zhang L; Zhang Y; Huang SM
    Mol Pharm; 2009; 6(6):1766-74. PubMed ID: 19839641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal drug transporters: an overview.
    Estudante M; Morais JG; Soveral G; Benet LZ
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1340-56. PubMed ID: 23041352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug metabolism in the lungs: opportunities for optimising inhaled medicines.
    Enlo-Scott Z; Bäckström E; Mudway I; Forbes B
    Expert Opin Drug Metab Toxicol; 2021 May; 17(5):611-625. PubMed ID: 33759677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.